-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $23

Benzinga·05/22/2026 15:36:07
Listen to the news
Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $18 to $23.